Breaking News Instant updates and real-time market news.

LJPC

La Jolla

$38.44

2.56 (7.13%)

18:32
03/20/17
03/20
18:32
03/20/17
18:32

La Jolla Pharma includes ATHOS-3 data in 'risk factors' warning

In a stock offering prospectus filed Monday, La Jolla Pharmaceutical included the following statement in a "risk factors" section: "Risks that the full data set from the ATHOS-3 study will not be consistent with the top-line results of the study."

  • 20

    Mar

  • 23

    Mar

LJPC La Jolla
$38.44

2.56 (7.13%)

02/27/17
JEFF
02/27/17
NO CHANGE
Target $40
JEFF
Buy
La Jolla price target raised to $40 from $27 at Jefferies
Jefferies analyst Eun Yang raised her price target for La Jolla Pharmaceutical to $40 after the company announced positive top-line results from the Phase 3 study of LJPC-501 in patients with catecholamine resistant hypotension. The stock in afternoon trading is up 82%, or $16.36, to $36.23. While a positive outcome was largely expected, a trend toward mortality benefit is encouraging and unexpected, Yang tells investors in a research note, citing her discussions with experts. Her new price target reflects 100% probability for LJPC-501 clinical success and pricing at parity to other hospital-based drugs. Yang keeps a Buy rating on La Jolla.
02/27/17
COWN
02/27/17
NO CHANGE
Target $55
COWN
Outperform
La Jolla price target raised to $55 from $40 at Cowen
Cowen analyst Phil Nadeau raised La Jolla's price target to $55 from $40 following compelling LJPC-501 data in its SPA-supported Phase III ATHOS-3 trial. The analyst believes the data de-risks LJPC-501 and expects the company to file for FDA approval in 2H 2017. Nadeau has a Buy rating on La Jolla shares.
02/28/17
RHCO
02/28/17
NO CHANGE
RHCO
La Jolla data positive, says SunTrust
SunTrust analyst Yatin Suneja believes that data on La Jolia's LJPC-501 was "highly favorable," supports its approval and suggests that it could become the standard of care in last-line CRH. The analyst thinks that the drug represents an opportunity of at least $500M, and he raised his price target on the name to $57 from $38 while keeping a Buy rating.
03/10/17
CHDN
03/10/17
NO CHANGE
Target $90
CHDN
Buy
Chardan has increased confidence in Top Pick La Jolla
Chardan said it has increased confidence in Top Pick La Jolla Pharmaceutica following meetings wit CEO, George F. Tidmarsh, MD, PhD, while the company was on a roadshow to meet with investors and analysts. The firm's analyst came away from the meeting more positive on the company's de-risked strategy towards drug development, and believes the potential of the strategy is supported by the recent success of LJPC-501 in catecholamine resistant hypotension in its pivotal phase III study, ATHOS-3.

TODAY'S FREE FLY STORIES

FFKT

Farmers Capital Bank

$42.60

0.4 (0.95%)

05:12
10/19/17
10/19
05:12
10/19/17
05:12
Earnings
Farmers Capital Bank reports Q3 EPS 71c, consensus 58c »

Reports Q3 tangible book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$52.30

0.3 (0.58%)

05:11
10/19/17
10/19
05:11
10/19/17
05:11
Downgrade
Nike rating change  »

Nike downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

GSBC

Great Southern Bancorp

$56.80

0.25 (0.44%)

05:10
10/19/17
10/19
05:10
10/19/17
05:10
Earnings
Great Southern Bancorp reports preliminary Q3 EPS 82c, consensus 82c »

Reports preliminary Q3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

TERP

TerraForm Power

$13.58

0.62 (4.78%)

05:06
10/19/17
10/19
05:06
10/19/17
05:06
Initiation
TerraForm Power initiated  »

TerraForm Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABT

Abbott

$55.77

0.71 (1.29%)

05:04
10/19/17
10/19
05:04
10/19/17
05:04
Recommendations
Abbott analyst commentary  »

Abbott price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$187.15

-10.63 (-5.37%)

05:00
10/19/17
10/19
05:00
10/19/17
05:00
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

MERC

Mercer

$13.50

-0.05 (-0.37%)

04:58
10/19/17
10/19
04:58
10/19/17
04:58
Upgrade
Mercer rating change  »

Mercer upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ADBE

Adobe

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

ANGI

Angie's List

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Upgrade
Angie's List rating change  »

Angie's List…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

GWW

Grainger

$208.81

3.39 (1.65%)

04:57
10/19/17
10/19
04:57
10/19/17
04:57
Downgrade
Grainger rating change  »

Grainger downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

MZOR

Mazor Robotics

$58.55

3.57 (6.49%)

, NUVA

NuVasive

$54.18

0.47 (0.88%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Downgrade
Mazor Robotics, NuVasive rating change  »

Mazor Robotics downgraded…

MZOR

Mazor Robotics

$58.55

3.57 (6.49%)

NUVA

NuVasive

$54.18

0.47 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

MTCH

Match Group

$25.52

-0.56 (-2.15%)

, IAC

IAC

$124.60

-0.55 (-0.44%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Jefferies Internet analysts hold an analyst/industry conference call »

Internet Analysts…

MTCH

Match Group

$25.52

-0.56 (-2.15%)

IAC

IAC

$124.60

-0.55 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 08

    Nov

  • 09

    Nov

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/13 EIA Natural…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/18 Fed Balance…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/9 Money Supply…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

6-Month Bill Announcement…

UBS

UBS

$17.26

0.02 (0.12%)

, CME

CME Group

$136.37

0.18 (0.13%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Futures Industry Association to hold an expo »

33rd Annual FIA Futures…

UBS

UBS

$17.26

0.02 (0.12%)

CME

CME Group

$136.37

0.18 (0.13%)

NDAQ

Nasdaq

$74.60

-0.11 (-0.15%)

ICE

IntercontinentalExchange

$68.20

0.03 (0.04%)

CBOE

CBOE Holdings

$109.59

0.06 (0.05%)

BAC

Bank of America

$26.48

0.28 (1.07%)

GS

Goldman Sachs

$242.03

5.94 (2.52%)

JPM

JPMorgan

$97.99

0.37 (0.38%)

CS

Credit Suisse

$15.91

-0.11 (-0.69%)

C

Citi

$73.12

0.93 (1.29%)

AMZN

Amazon.com

$997.00

-12.13 (-1.20%)

MS

Morgan Stanley

$50.15

1.03 (2.10%)

WFC

Wells Fargo

$53.41

0.22 (0.41%)

AMTD

TD Ameritrade

$47.54

0.32 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 20

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 02

    Nov

  • 02

    Nov

  • 05

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 20

    Nov

  • 29

    Nov

  • 15

    Jan

  • 27

    Feb

  • 18

    Mar

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

SNY

Sanofi

$49.53

-0.06 (-0.12%)

, PFE

Pfizer

$35.83

-0.37 (-1.02%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Drug Information Association to hold a conference »

Metrics in…

SNY

Sanofi

$49.53

-0.06 (-0.12%)

PFE

Pfizer

$35.83

-0.37 (-1.02%)

ALKS

Alkermes

$51.09

-0.39 (-0.76%)

LLY

Eli Lilly

$85.73

-0.33 (-0.38%)

BMY

Bristol-Myers

$63.70

-0.48 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 20

    Oct

  • 20

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 31

    Oct

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 09

    Nov

  • 05

    Mar

VPG

Vishay Precision

$24.40

0.55 (2.31%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Vishay Precision management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 07

    Nov

SCS

Steelcase

$15.30

0.1 (0.66%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Steelcase management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 25

    Oct

  • 26

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Philadelphia Fed Business Outlook Survey General Conditions Index to be reported at 08:30 »

October Philadelphia Fed…

SB

Safe Bulkers

$3.12

-0.01 (-0.32%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Safe Bulkers management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

COST

Costco

$157.55

-0.83 (-0.52%)

04:55
10/19/17
10/19
04:55
10/19/17
04:55
Conference/Events
Costco management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Kansas City Federal…

04:55
10/19/17
10/19
04:55
10/19/17
04:55
General news
Breaking General news story  »

Week of 10/15 Bloomberg…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.